Related Experiment Video
Updated: Dec 21, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Suppressed immune profile in children with combined type 1 diabetes and celiac disease
A Tompa1,2, K Åkesson3, S Karlsson1
1The Biomedical platform, Department of Natural Science and Biomedicine, School of Health and Welfare, Jönköping University, Jönköping, Sweden.
Insights
Children with both type 1 diabetes (T1D) and celiac disease (CD) exhibit a suppressed immune profile, with lower levels of key immune markers. This finding highlights the complex interplay of immune dysregulation in these co-occurring autoimmune conditions.
Area of Science:
- Immunology
- Endocrinology
- Gastroenterology
Background:
- Type 1 diabetes (T1D) and celiac disease (CD) are autoimmune disorders with overlapping immune dysregulation.
- Previous research has focused on cellular immunity and limited soluble markers in co-diagnosed children.
- The role of adipocytokines and matrix metalloproteinases (MMPs) in combined T1D and CD remains largely unexplored.
Purpose of the Study:
- To investigate the peripheral immunoregulatory milieu in children with co-occurring T1D and CD.
- To analyze serum levels of 28 immune markers, including cytokines, chemokines, acute-phase proteins (APPs), adipocytokines, and MMPs.
- To compare these markers between children with combined T1D and CD, T1D alone, CD alone, and healthy controls.
Main Methods:
- Serum samples were collected from four groups: T1D and CD (n=18), T1D (n=27), CD (n=16), and controls (n=42).
- The Luminex technique was employed to analyze the levels of 28 immune markers.
- Statistical analysis was performed to compare marker levels across the groups.
Main Results:
- Children with combined T1D and CD demonstrated significantly lower serum levels of interleukin-22 (IL-22), monocyte chemoattractant protein-1 (MCP-1), monocyte chemoattractant protein-1 alpha (MIP-1α), procalcitonin, fibrinogen, visfatin, and matrix metalloproteinase-2 (MMP-2).
- These findings suggest a generally suppressed immune profile in children with the double diagnosis.
- The suppressed profile encompassed Th17 cytokines, chemokines, APPs, adipocytokines, and MMPs.
Conclusions:
- Children with co-occurring T1D and CD exhibit a distinct, suppressed immune profile compared to those with single diagnoses or healthy controls.
- Beyond cytokines and chemokines, APPs, adipocytokines, and MMPs are crucial for understanding the complex immune processes in T1D and CD.
- Further research is warranted to elucidate the heterogeneous immune mechanisms in patients with combined T1D and CD.
Abstract:
Children diagnosed with a combination of type 1 diabetes (T1D) and celiac disease (CD) show a dysregulated T helper type 1 (Th1)/Th17 response. Besides the cellular involvement, several soluble immune markers are involved in the autoimmune process of both T1D and CD. Only few studies have examined the peripheral pattern of different cytokines, chemokines and acute-phase proteins (APP) in children with combined T1D and CD. To our knowledge, no studies have evaluated the serum levels of adipocytokines and matrix metalloproteinases (MMPs) in this context. The purpose of the present study was to acquire more knowledge and to gain deeper understanding regarding the peripheral immunoregulatory milieu in children with both T1D and CD. The study included children diagnosed with both T1D and CD (n = 18), children with T1D (n = 27) or CD (n = 16) and reference children (n = 42). Sera were collected and analysis of 28 immune markers (cytokines, chemokines, APPs, adipocytokines and MMPs) was performed using the Luminex technique. The major findings showed that children with a double diagnosis had lower serum levels of interleukin (IL)-22, monocyte chemoattractant protein (MIP)-1α, monocyte chemoattractant protein (MCP)-1, procalcitonin, fibrinogen, visfatin and matrix metalloproteinase (MMP)-2. These results indicate a suppressed immune profile in children with combined T1D and CD, including Th17 cytokines, chemokines, APPs, adipocytokines and MMPs. We conclude that, besides cytokines and chemokines, other immune markers, e.g. APPs, adipocytokines and MMPs, are of importance for further investigations to elucidate the heterogeneous immune processes present in patients diagnosed with T1D in combination with CD.
More Related Videos
14:01Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Diabetes: Symptoms, Diagnosis, and Complications